Amedisys (NASDAQ:AMED) Shares Gap Up – Here’s What Happened

Amedisys, Inc. (NASDAQ:AMEDGet Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $85.95, but opened at $89.50. Amedisys shares last traded at $89.46, with a volume of 536,164 shares changing hands.

Amedisys Stock Up 4.7 %

The business has a fifty day moving average price of $90.45 and a two-hundred day moving average price of $94.43. The firm has a market capitalization of $2.95 billion, a price-to-earnings ratio of 35.70, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19.

Amedisys (NASDAQ:AMEDGet Free Report) last released its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The business had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.98 EPS. On average, equities analysts expect that Amedisys, Inc. will post 4.45 earnings per share for the current year.

Institutional Trading of Amedisys

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AMED. Polar Asset Management Partners Inc. acquired a new stake in shares of Amedisys in the third quarter valued at approximately $28,953,000. SG Americas Securities LLC grew its holdings in Amedisys by 413.4% during the third quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock worth $18,985,000 after acquiring an additional 158,398 shares during the period. Verition Fund Management LLC lifted its stake in shares of Amedisys by 608.1% in the third quarter. Verition Fund Management LLC now owns 114,774 shares of the health services provider’s stock valued at $11,077,000 after purchasing an additional 98,565 shares during the period. Westchester Capital Management LLC lifted its position in shares of Amedisys by 9.5% during the 3rd quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider’s stock valued at $107,976,000 after acquiring an additional 97,476 shares during the period. Finally, Highbridge Capital Management LLC grew its holdings in Amedisys by 34.7% in the second quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock valued at $29,670,000 after purchasing an additional 83,200 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

About Amedisys

(Get Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Read More

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.